ClinicalTrials.govpublic full text
SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer
pancreatic cancer, sbrt, ipilimumab, sintilimab, locally advanced pancreatic cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 844713
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.